An offering of 0.4% senior notes due 2024 and 1.3% senior notes due 2029 has been completed by Baxter, generating around $1.68 billion. The company has not disclosed how it intends to use the proceeds.
Senior notes offering pulls in nearly $1.7B for Baxter
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.